Sign in
Active, not recruitingPhase 3

mHealth Mindfulness Intervention for Pregnant Black and Latina Women at Risk of Postpartum Depression

Key facts

Who runs it
Kaiser Permanente
Where
Oakland, United StatesSee the site
Trial code
Status
Active, not recruiting
Phase
Phase 3
People taking part
600 people, planned
Started
14 Jun 2022
Ended
Dec 2025
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Stress reduction program 'A'
  • Stress reduction program 'B'
Record updated
5 August 2025

Who can take part

Age
18 years and older
Sex
Women only
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 13 criteriaShow less

Who can take part

  • Age ≥18 years
  • Current Kaiser Permanente Permanente Northern California (KPNC) member
  • Pregnant woman receiving prenatal care at KPNC
  • Gestational age <30 weeks
  • Singleton pregnancy
  • Self-identify as Black and/or Latina
  • Moderate to moderately severe depressive symptoms (PHQ-9 score between 10 and 19) and no indication of suicidality
  • Owns a device with internet access
  • English- or Spanish-speaking

Who cannot take part

  • Regular stress reduction practice with a mindfulness component (e.g., meditation or yoga more than twice a week)
  • Deaf
  • Blind
  • Acting as gestational carrier/surrogate

Where in United States

  • Kaiser Permanente Northern CaliforniaOakland, United States

About the trial

What the trial wants to find out

Postpartum depression (PPD) is associated with significant health consequences for mothers and children, and the current COVID-19 pandemic has had a major impact on the mental health of particularly vulnerable populations including pregnant Black and Latina women. There is an urgent need for evidence-based, accessible, and scalable mental health care options for these high-risk, vulnerable women. This study aims to: (a) compare the effectiveness of two digitally-delivered self-paced stress reduction programs in pregnant Black and Latina women at increased risk of PPD; and (b) examine barriers and facilitators to implementation within a large healthcare system.

The 2 groups in the trial

  • InterventionTreatment being tested

    Use of mHealth stress reduction program 'A' app 5-20 min daily for 6 weeks

    Treatment: Stress reduction program 'A'

  • Active controlExisting treatment, for comparison

    Use of mHealth stress reduction program 'B' app 5-20 min daily for 6 weeks

    Treatment: Stress reduction program 'B'

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Publications
Record updated
5 August 2025